Crossmark

Effect of intravenous immunoglobulin on the management of Rh- and ABO-mediated hemolytic disease of the newborn

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.03.002

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jalali, Seyedeh Zohreh http://orcid.org/0000-0002-5897-9982
Mahdipour, Sadroddin http://orcid.org/0000-0002-2363-3658
Asgarzad, Roya

Saadat, Farshid http://orcid.org/0000-0002-5457-4195
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-04-09
More Information

This article is maintained by: Elsevier

Article Title: Effect of intravenous immunoglobulin on the management of Rh- and ABO-mediated hemolytic disease of the newborn

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.03.002

Content Type: article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.